Indexed metadata

Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study

Eva Havrdová, Anna Belova, Alla Goloborodko, Anne Tisserant, Andrew Wright, Erik Wallstroem, Hideki Garren, Ralph Paul Maguire, Donald R. Johns

Source record

Source: Crossref

Published: May 3, 2016

DOI: 10.1007/s00415-016-8128-x

Open original source ↗

Evidence graph

No public relationships recorded yet.

Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.

Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study — Mathematical Frontier Network